Publications by authors named "Emily McCall"

Study Objective: Determine if independently suturing the vaginal cuff angles in addition to running barbed suture has an effect on patients' perception of postoperative bleeding after laparoscopic hysterectomy.

Design: Randomized controlled trial.

Setting: University-based medical center.

View Article and Find Full Text PDF

Introduction: The ubiquitin-proteasome system (UPS) is an intracellular organelle responsible for targeted protein degradation, which represents a standard therapeutic target for many different human malignancies. Bortezomib, a reversible inhibitor of chymotrypsin-like proteasome activity, was first approved by the FDA in 2003 to treat multiple myeloma and is now used to treat a number of different cancers, including relapsed mantle cell lymphoma, diffuse large B-cell lymphoma, colorectal cancer, and thyroid carcinoma. Despite the success, bortezomib and other proteasome inhibitors are subject to severe side effects, and ultimately, drug resistance.

View Article and Find Full Text PDF
Article Synopsis
  • Tyrosine kinase inhibitors (TKIs) have transformed chronic myeloid leukaemia (CML) from a deadly condition into a manageable one, but drug-resistant leukaemia stem cells present a significant challenge for achieving a cure.
  • A new study highlights the downregulation of the G0/G1 switch gene 2 (G0S2), a key regulator of lipid metabolism, in various instances of TKI resistance, which correlates with poorer survival outcomes for patients.
  • The research indicates that the decrease in G0S2 is influenced by transcriptional repression from MYC rather than by genetic changes or BCR::ABL1 activity, suggesting that restoring G0S2 could be crucial for improving treatment responses
View Article and Find Full Text PDF